These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33144089)

  • 1. Liver Biopsy Shines a Light on COVID-19-Related Liver Injury.
    Kleiner DE
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):881-882. PubMed ID: 33144089
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver diseases in COVID-19: Etiology, treatment and prognosis.
    Wu J; Song S; Cao HC; Li LJ
    World J Gastroenterol; 2020 May; 26(19):2286-2293. PubMed ID: 32476793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic insight into COVID-19-related liver injury.
    Bianco C; Baselli G; Malvestiti F; Santoro L; Pelusi S; Manunta M; Grasselli G; Bandera A; Scudeller L; Prati D; Valenti L
    Liver Int; 2021 Jan; 41(1):227-229. PubMed ID: 33098230
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19-associated liver injury (COVALI): role of hepatologists.
    Sumida Y; Yoneda M
    J Gastroenterol; 2021 Aug; 56(8):786-787. PubMed ID: 34212231
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 and the liver: What do we know after six months of the pandemic?
    Fierro NA
    Ann Hepatol; 2020; 19(6):590-591. PubMed ID: 32956871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
    Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
    Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covid-19 infection, liver injury and prognosis: a suggestion.
    Testino G
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):451-452. PubMed ID: 32558696
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastrointestinal and liver manifestations of COVID-19.
    Cheong J; Bartell N; Peeraphatdit T; Mosli M; Al-Judaibi B
    Saudi J Gastroenterol; 2020; 26(5):226-232. PubMed ID: 32367837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology and management of liver injury in patients with COVID-19.
    Yang RX; Zheng RD; Fan JG
    World J Gastroenterol; 2020 Aug; 26(32):4753-4762. PubMed ID: 32921955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
    Wang H; Qiu P; Liu J; Wang F; Zhao Q
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):653-661. PubMed ID: 32418852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical manifestations and management of COVID-19-related liver injury.
    Su TH; Kao JH
    J Formos Med Assoc; 2020 Jun; 119(6):1016-1018. PubMed ID: 32345544
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver injury in COVID-19: management and challenges.
    Zhang C; Shi L; Wang FS
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):428-430. PubMed ID: 32145190
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppression.
    Lubnow M; Schmidt B; Fleck M; Salzberger B; Müller T; Peschel G; Schneckenpointner R; Lange T; Hitzenbichler F; Kieninger M; Lunz D; Graf B; Brochhausen C; Weber F; Lüke F; Peterhoff D; Schuster P; Hiergeist A; Offner R; Hehr U; Wallner S; Hanses F; Schmid S; Weigand K; Geismann F; Poeck H; Pukrop T; Evert M; Gessner A; Burkhardt R; Herr W; Maier LS; Heudobler D
    Int J Infect Dis; 2021 Feb; 103():624-627. PubMed ID: 33412272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 pandemic: Its impact on liver disease and liver transplantation.
    Sahin TT; Akbulut S; Yilmaz S
    World J Gastroenterol; 2020 Jun; 26(22):2987-2999. PubMed ID: 32587443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.
    Ji D; Xu J; Qin E; Zhang D; Cheng G; Wang Y; Lau G
    J Hepatol; 2020 Sep; 73(3):718-719. PubMed ID: 32387073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.